Ambulatory Surgical Centres Market Covid-19 Impact Analysis, Size, Share, Key Trends, Demand and Forecast till 2031

As per a recent study by Future Market Insights (FMI), the global Ambulatory Surgical Centers Market totaled US$ 85.4 Bn in 2020. With sales growing at a 3.9% CAGR, the market valuation is poised to reach US$ 130.6 Bn by 2031.

Increasing number of clinical procedures such as lithotripsy, coronary angiography, hemodialysis, radiotherapy (for cancer), and chemotherapy is driving demand for ambulatory surgical centers. Earlier, all clinical condition were treated in the hospital, be it a simple suturing procedure or a deep invasive procedure. These minimal invasive procedures led the count of inpatient admissions to increase, resulting in disorganization in the hospital environment.

When a common outpatient procedure is performed in the ambulatory surgical center it saves up to 59% of the total spending, according to the Ambulatory Surgery Center Association.

These factors are driving investments in hospitals for the establishment of ambulatory surgical centers. This is expected to create lucrative opportunities for platers operating in the market, especially in developing regions.

“Growing demand for mobile healthcare services, coupled with favorable government policies encouraging the establishment of these centers in rural areas is expected to drive the market in the forthcoming years,” says an FMI analyst.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-5071

Key Takeaways:

  • By centers type, the multispecialty centers segment is projected to account for 66.2%of the total market share in 2021, expanding at 4.3% CAGR during the forecast period.
  • Based on modality, the hospital-based segment is forecast to hold 60.2% of the market share in 2021.
  • Sales in the surgical services segment are anticipated to account for 68.1% of the total market share in 2021.
  • Demand in the gastroenterology segment is expected to command 30% of the total market share over the assessment period.
  • The U.S. forecast to account for 88.3% of the North America market share over the assessment period.
  • Sales in Germany are forecast to command 31.6% of the Europe market share in 2031.
  • China will emerge as a lucrative market, holding 45% of the East Asia market share over the forecast period.

Who is winning?

Key market players covered by FMI include AmSurg Corp, Tenet Healthcare, HCA Holdings, Inc., Surgical Care Affiliates, Inc., Surgery Partners, and Ambulatory Surgical Centers of America.

Leading players operating in the global ambulatory surgical centers market are focusing on new service offering, collaborations, and partnerships to improve their product portfolios, and to strengthen their global presence.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-5071

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Smart Insulin Pens Market 2022 End-User Demand by Types, Regions, Top Players, Regional Outlook and Forecast to 2031

ESOMAR-certified consulting firm Future Market Insights (FMI) projects the global smart insulin pens market is likely to surpass the billion dollar mark by 2021, expanding at a positive CAGR, as per a newly published research report. A stupendous double digit growth rate has been predicted for the market in the long-run. Growing preference for non-invasive treatment and the ever widening diabetes burden are likely to steer the market in a forward direction.

According to FMI’s report, the market posted significant gains in the past, with Bluetooth smart insulin pens generating over 30% of the revenue share in 2017. Also, according to the International Diabetes Federation, presently, just under half a billion people are living with diabetes worldwide, and their number is projected to increase by 25% in 2030, and 51% by 2045 respectively.

Manufacturers, therefore, are leveraging these trends to introduce novel and innovative product lines, enabling them to secure a firm footing in the market. In November 2020, for instance, Medtronic launched its InPenTM smart insulin device equipped with real-time GuardianTM Connect CGM Data- the first smart insulin pen for diabetics on multiple daily injections. Recently, in April 2021, BioCorp and Roche Diabetes Care launched the Mallya smart insulin pen device in France.

To remain ahead of your competitors, request for a sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-1827

Key Takeaways from FMI’s Smart Insulin Pens Market Report

  • By connectivity, Bluetooth connected smart insulin pens to account for over half of the revenue share by 2031
  • By indication, type 2 diabetes treatment to account for the bulk of smart insulin pens deployment
  • Retail pharmacies were the primary distribution channels for smart insulin pens, e-commerce sales spiking rapidly
  • US to experience credible growth amid increasing approval rates for new diabetes management devices
  • Growing preference for needle-free insulin injections to widen adoption across the UK
  • Germany & France to experience increased collaborations between key manufacturers in the long-run
  • Large concentration of regional level manufacturers to pivot growth across India and China

Smart Insulin Pens Market – Key questions answered in the report

  • What trends are in store for the smart insulin pens market growth?According to FMI, the global smart insulin pens market is likely to register a multi-billion dollar valuation in the short and long-run forecasts, attributed to a general increase in the global diabetic population pool and the consequent increase in hospital workload. Demand for Bluetooth connected smart insulin pens is expected to remain especially high
  • Which is the most promising smart insulin pens market?As per FMI’s analysis, demand for smart insulin pens are expected to remain high across the US market, attributed to unceasing efforts by the government to eradicate the diabetes epidemic by virtue of extensive advertising campaigns. Additionally, India and China are expected to emerge as the dominant markets in the Asia-Pacific region, characterized by the presence of numerous regional level manufacturers

Which prominent players operate in the global smart insulin pens market?

  • Digital Medics Pty Ltd.,
  • Emperra GmbH e-Health Technologies,
  • Companion Medical Inc.,
  • Sanofi Aventis LLC,
  • Novo Nordisk A/S,
  • Eli Lily and Company,
  • Companion Medical,
  • Diabnext,
  • Jiangsu Delfu Medical Device Co. Ltd.,
  • DIAMESCO Co Ltd.,
  • Patients Pending Ltd (Bigfoot Biomedical Inc.),
  • BERLIN-CHEMIE

are some major smart insulin pens manufacturers profiled in FMI’s report

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-1827

Competitive Landscape

Major insulin pens manufacturers are effectively leveraging major expansion strategies, ranging from new product launches and R&D to collaborating with existing manufacturers or outright/partial acquisition of key market players. A major emphasis is being laid on incorporating virtual technological advancements to enhance diabetes management.

In February 2021, Novo Nordisk and the University of Toronto announced a CAD 40 million investment deal to establish the Novo Nordisk Network for Healthy Populations. This network will focus on new approaches to address diabetes and aid in chronic disease prevention. This will likely help broaden smart insulin pens development.

Companies are also focusing on providing advanced software platforms, such as Digital Medics’ DiabetesPlus DataSync Software. This platform enables users to download insulin and glucose data directly from the device. Key features include downloading insulin data from the insulin pen, glucose levels from the glucose meter and synchronization of data on the Cloud for use with mobile devices.

According to FMI’s report, the following insulin pens manufacturers currently operate in the global market:

  • Digital Medics Pty Ltd.
  • Emperra GmbH e-Health Technologies
  • Companion Medical Inc.
  • Sanofi Aventis LLC
  • Novo Nordisk A/S
  • Eli Lily and Company
  • Diabnext
  • Jiangsu Delfu Medical Device Co. Ltd.
  • DIAMESCO Co Ltd.
  • Patients Pending Ltd (Bigfoot Biomedical Inc.)
  • BERLIN-CHEMIE

Smart Insulin Pens Market – Key Segments Covered

Indication

  • Diabetes Type I
  • Diabetes Type II

Connectivity

  • Bluetooth Connected
  • USB Connected

Distribution Channel

  • Clinics & Ambulatory Surgical Centers
  • E-Commerce
  • Retail Pharmacies

Region

  • North America (US and Canada)
  • Europe (Germany, UK, France, Spain, Italy and Rest of Europe)
  • Asia-Pacific (India, China, Australia & New Zealand, Japan and Rest of APAC)
  • Rest of the World (Brazil, Mexico, GCC and South Africa)

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1827

 

Airway Clearance Devices System Market Industry Analysis, Opportunities, Technology, Demand, Top Players and Growth Forecast 2027

Airway Clearance Devices System Market: Drivers and Restraints

Conventional methods like chest physiotherapy used for bronchial drainage in different types of respiratory dysfunction. However traditional chest physiotherapy is time-consuming and labour intensive both for non-hospitalized and hospitalized patients. On the counterpart, airway clearance devices systems increasing the compliance with patients and is the less time-consuming process. Reduced cost and independent application are other reason for changing the preference of patient population from conventional chest physiotherapy to airway clearances devices system market. All these factors influencing the burgeoning growth of the airway clearances devices system. Others factors like decreased respiratory complications and demand for devices over conventional methods drives the growth of the airway clearance devices system market.

Limited availability of evidence based data for effectiveness of devices act as a restraint on the growth of the airway clearance devices system market

Airway clearance devices systems are used to remove excess mucus from lungs. The excess production of mucus is a common feature in the COPD (chronic obstructive pulmonary disease) and it leads to accumulation of mucus in the air way. It results in the coughing, wheezing, chronic bronchitis, emphysema and shortness of breath. There are few types of airway clearance devices system, namely: positive expiratory pressure devices, intrapulmonary percussive ventilation, oral high-frequency oscillation, high-frequency chest wall oscillation, flutter devices, and incentive spirometry. Positive expiratory pressure devices is an alternative to conventional physiotherapy, and it consists of the one-way valve to which expiratory resistance is applied. Intrapulmonary percussive ventilation devices combine internal thoracic percussion and aerosol inhalations. Oral high-frequency oscillation is worked on the principle of high frequency and low volume of oscillations, and it is developed from the technique of jet ventilation with high frequency. High-frequency chest wall oscillation devices is a mechanical device which works on the principle of positive pressure air pulse on the lungs by means of air pulse generator and inflatable chest. Flutter devices is a combination of high-frequency oscillations with positives expiratory pressure therapy. Incentive spirometry is used to measure inspiratory effort by using air volume and air flow.

Airway Clearance Devices System Market: Market Overview

Global Airway Clearance Devices System market has witnessed a robust growth due to increasing demand due to improving respiratory drainage and reduced infections. Airway Clearance Devices System market has a presence of many regional players which have a huge market share in emerging countries operating at regional or country level. The future of Airway Clearance Devices System market anticipated with double CAGR during forecasting period.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-5230

Airway Clearance Devices System Market: Key Participants

The key participants in the Airway Clearance Devices System market mainly include Monaghan Medical Corporation, Koninklijke Philips N.V., Vortran Medical Technology and others. Companies are mainly focused on R&D to strengthen core competencies of the company’s product portfolio.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also includes projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends and Issues and Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Rest Of Latin America)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC countries, S. Africa, N. Africa, Rest Of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-5230

Airway Clearance Devices System Market: Segmentation

Segmentation based on product type

  • Positive expiratory pressure devices
  • Intrapulmonary percussive ventilation
  • Oral high-frequency oscillation
  • High-frequency chest wall oscillation
  • Flutter devices and
  • Incentive spirometry

Segmentation based on End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/5230

Dental Delivery System Market Analysis, Recent Trends and Regional Growth Forecast by 2027

Dental Delivery System Market: Overview

Dental delivery systems available in the market differ by modality type, technical innovation, functionality and durability. Associated cost with the product is proportional to the advanced modalities. There are numerous players in the dental delivery system market value chain involved for the manufacturing as well as supply of these equipments to various end users. The prevalence rate of oral diseases is differed depending on the geographical region, availability and accessibility to the oral health services, demand for dental appliances, operator preference and cost effectiveness are the dynamics which vary the market growth across different geographies.

Dental delivery systems encompasses integration capabilities and choice of mounting locations for all the dental equipments required in an operator. Choice of dental delivery system depends on the method of dentistry practice followed. These systems are designed in order to improve dental practice efficiency. Functionality and placement of delivery units is the critical component to operatory layout which differentiate the units on the basis of modality as fixed, portable or carts. Fixed systems are available as rear delivery systems, side delivery systems, over the head delivery system and over the patient delivery systems.

Portable dental delivery systems are self-contained units which assist the dentist to carry the kit anywhere required and also eliminates any special installation. This unit design meets the necessities of time and motion concept and encourages good ergonomic positioning so to easily access the hand pieces even if the dentist is working alone. These systems also provides the most practical use of space. Typical dental delivery systems accommodates at least three hand pieces, a control panel with wet/dry foot control, airflow control, self-contained waterline with asepsis tubing and purge system. Along with this, there is an option to accommodate various accessories within the system such as lighting, x-ray viewers, touchpads, fibre optic systems etc. for enhancing the application of dental delivery systems.

These systems are long term investment for a dental professional in order to improve the productivity of one’s practice. The evolvement in the dental care systems over the years motivates the use of newer appliances like dental delivery system.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-5228

Dental Delivery System Market: Drivers & Restraints

Improvement in oral healthcare facilities and use of advanced appliances in dental practice supports the growth for dental delivery systems market. Advancement in the engineering techniques for medical equipments manufacturing also fuel the market growth. Growing cosmetic dentistry, increasing awareness about dental care, emerging dental practice and increasing dental tourism industry also spur the market for these dental appliances. However, heavy taxation on dental devices and high cost of advanced dental equipment can hamper the growth of the market for dental delivery systems. Inaccessibility and unaffordability of dental services in various geographies across globe also hinders the market growth for various dental appliances such as dental delivery systems.

Dental Delivery System Market: Region-wise Outlook

North America is the leading market for dental delivery systems usage owing to the established market for dental appliances and availability of various players supplying these equipment. Along with this, high demand of dental procedures and established healthcare infrastructure supports the market growth over the region. This is followed by Western Europe owing to high number of dental professionals and available facilities in the region as well as adoption of new technology for advancing healthcare. Asia Pacific represents the most lucrative market in terms of high growth rate over the region because of increasing awareness for dental care, rising disposable income and advancement of healthcare facilities. Latin America followed by MEA represents the least lucrative market for the growth of dental delivery systems market growth.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-5228

Dental Delivery System Market Treatment Market: Key Players

Some of the players in the Dental Delivery System service market includes Flight Dental Systems, Aseptico, Dental EZ group, Pelton & Crane, Safari Dental Inc., Tenko Medical Systems, ETI Dental Industries, Dynamic Group, DNTLworks, A-dec Inc., ASI dental and others.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends and Issues and Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain
Dental Delivery System Market: Segmentation

Segmentation by Modality

  • Fixed dental delivery systems
  • Rear-delivery systems
  • Side-delivery systems
  • Over-the-patient systems
  • Over-the-head systems
  • Portable dental delivery ystems
  • Dental Delivery Carts

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/5228

Segmentation by End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Dental Clinics

Genitourinary Prosthetics Market Industry Insight and Growth Strategy by Business Players and Forecast To 2027

Prosthesis, in general is an artificial medical device that is used to replace any missing part that might have lost during trauma, congenital conditions or infectious disease. Prosthetist or a team of healthcare experts commonly including surgeons, physical therapists, psychiatrists, and occupational therapists coordinate with each other to offer smooth services in prosthetic amputee rehabilitation. The genitourinary system in a human body constitutes the organs of reproductive system and the urinary system as they are present in proximity to each other and also use the common pathways. Genitourinary system undergo many disorders that are majorly caused due to infectious diseases, disease conditions in urinary structure, congenital anomalies, or trauma. Genitourinary prosthetics deals with the diagnosis and treatment of diseases occurring in the urinary tract and male or female genital tract. Genitourinary prosthetics are used to treat urinary incontinence and are available in distinct types as prosthetic devices, prosthetic implants, and genitourinary prosthetic grafts. Genitourinary prosthetic implant is a medical device that replaces or supports a missing or damaged biological structure in the body, respectively. They are made up of either silicon, titanium or apatite depending upon the requirement of the occupational therapists or prosthetist. The implantable prosthetic devices have been developed to restore genitourinary function and evolved from the electrical stimulation techniques to increase outlet resistance of urethra. Whereas, genitourinary graft is a surgical procedure in which tissue from one site of the body is transferred to another site. Two types of grafts, namely, synthetic mesh and biological mesh are used to treat genitourinary diseases. Genitourinary prosthetics are utilized in management of a distinct number of urologic conditions so as to restore function of infected area and improves the life of affected patients. Erectile dysfunction is one of the most common type of genitourinary dysfunction. As per U.S. Department of Health and Human Services, about 30 million men in the United States have been affected by it which ultimately leads to depression, anxiety, unsatisfied life. Urologists and healthcare professionals prefer to choose penile prosthetics to treat erectile dysfunction and provide a quality life to the patient. Thus the rising incidence of erectile dysfunction and infectious disease is driving the demand for genitourinary prosthetics, thereby increasing revenue generation in global genitourinary prosthetics market. There are several risk factors for developing erectile dysfunction that would drive the growth for genitourinary prosthetics market. Some of these risk factors include hormonal and physical changes, type 2 diabetes, atherosclerosis, chronic kidney disease, Peyronie’s disease, surgery for bladder cancer and others. Due to the rising prevalence of risk factors associated with erectile dysfunction, genitourinary prosthetics market registers a robust growth.

Genitourinary Prosthetics market is growing worldwide as women and men across the globe are lately experiencing urinary conditions that could be wisely treated using genitourinary prosthetics. Genitourinary prosthetics market includes various types that involves testicular prosthetics, artificial urinary sphincter, and penile prosthetics. The Genitourinary Prosthetics market lately has been categorized on the basis of type of material used to manufacture prosthetics as: silicon, titanium and apatite.

Genitourinary Prosthetics: Market Dynamics

Steady innovation in the prosthetics technology, availability of advanced materials for manufacturing prosthetic devices including low-temperature polyethylene therephthalate (LPET), polyetheretherketone (PEEK), silicon and rising adoption of these medical devices over the globe are some of the key factors driving the growth of genitourinary prosthetics market. Rise in risk factors associated with onset of chronic infectious diseases and growing preference of women and men for treatment of genitourinary conditions coupled with the rise in awareness among patients regarding genitourinary prosthetics is further boosting genitourinary prosthetics market across the globe. However, low reimbursement cuts associated with genitourinary prosthetics and high costs for advanced technology is expected to restrain the genitourinary prosthetics market growth.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-5224

Genitourinary Prosthetics Market: Region-wise Outlook

On the basis of geography, global genitourinary prosthetics market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa. North America holds the largest revenue shares followed by Europe in the global genitourinary prosthetics market on the account of rising demand for genitourinary prosthetics and availability of enhanced technology in genitourinary prosthetic devices. However, Asia-Pacific is anticipated to register the fast growth in genitourinary prosthetics market during the forecast period due to the rising incidence for diabetes and chronic infections in genitourinary system. Also, Western Europe is anticipated to register a slow growth in global genitourinary prosthetics market over the coming years.

Genitourinary Prosthetics Market: Key Players

Some of the key players present in global genitourinary prosthetics market are Boston Scientific Corporation, Zephyr Surgical Implants SÀRL, Coloplast Care, Promedon, UroMed, and others

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geography, grade, form and applications.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends and Issues and Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-5224

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Rest Of Latin America)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC countries, S. Africa, N. Africa, Rest Of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Genitourinary Prosthetics Market: Segmentation

The global genitourinary prosthetics market is segmented on the basis of product type, material type, end user, and region:

Segmentation by Product Type

  • Genitourinary Prosthetic Devices
  • Catheter
  • Electronic Stimulator Device
  • Stent
  • Genitourinary Prosthetic Implants
  • Artificial Urinary Sphincter Implant (AUS)
  • Inflatable Penile Implant (IPP)
  • Testicular Prosthetic Implant
  • Genitourinary Prosthetic Grafts
  • Synthetic Mesh
  • Biological Mesh
  • Allograft
  • Xenograft
  • Suture Anchors

Segmentation by Material Type

  • Silicon
  • Titanium
  • Apatite

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-5224

Segmentation by End User

  • Hospitals
  • Prosthetics clinics
  • Rehabilitation Center
  • Outpatient Surgical Centers

Mycology Immunoassays Testing Market Growth Share, Industry Dynamics, Top Trends and Regional Analysis Forecast to 2027

Mycology Immunoassays testing Market: Regional Outlook

Region wise, the global mycology immunoassays testing market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and Middle East and Africa. North America expected to dominate the global market for mycology immunoassays testing market high adoption of mycology immunoassay tests, wide availability of healthcare, pharmaceutical & biotechnology companies.  Similarly, large patient pool in the Asia –Pacific excluding Japan market are expected to boost the growth of the mycology immunoassay testing market for the hospitals and research centers segments growth in APEJ region over the forecast period.

The frequency of invasive fungal infections has dramatically increased in the recent years and has high mortality and morbidity. Accurate and early diagnosis is very important for the appropriate antifungal therapy. Conventional techniques like microbiology, radiological and histological remain the basis of diagnosis but have limited impact on clinical decision making. There is always a need to characterize fungi accurately and quickly, which can be done by mycology immunoassays test. The fungi are parasitic and saprophytic eukaryotic organisms. The diagnostic methods for fungal infections are direct examination, radiology, and fungal culture and non-culture methods. Diabetic patients are more susceptible to infectious diseases such as Cryptococcus, mucocutaneous candidosis and dematiaceous fungal infection. Rapid and accurate diagnosis of these life threatening fungal diseases is of clinical importance. Mycology is concerned with the study of the fungi. Histopathology, microscopy and use of fungal-specific stains plays an important role in the diagnosis of infections.

Fungi cause disease in man by virtue of their allergenicity, toxigenicity or pathogenicity. Mycology immunoassays are used to detect products or host responses to infection.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-5277

Mycology Immunoassays testing Market: Drivers and Restraints

The key factor responsible for the growth of mycology immunoassays testing market is increasing aging population and rising prevalence of chronic diseases and infectious diseases and increased variety of reagents and analytical techniques. Innovative new technologies have the potential to meet the needs of both resource-limited and resource-rich clinical environments. Increasing prevalence and severity of fungal infections in the recent years is driving the market growth of the global mycology immunoassays testing market. In addition, the advancement in treatment and medical care the mycology immunoassays market is increasing globally. However, the diagnosis of fungi is challenging because of lack of specificity and sensitivity.

Mycology Immunoassays testing Market: Key Players

The major key players in global mycology immunoassays testing markets are F. Hoffmann-La Roche Ltd, Abbott Laboratories, Inc., Siemens AG, Beckman Coulter, Inc., Ortho-Clinical Diagnostics, Inc., bioMérieux SA, ELITechGroup and MiraVista Diagnostics.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends and Issues and Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-5277

Mycology Immunoassays testing Market: Segmentation

The global mycology immunoassays testing market is segmented on the basis of technology and end user

On the basis of technology the global mycology immunoassay testing market is segmented into

  • ELISA
  • Rapid Tests
  • ELISPOT
  • Polymerase Chain Reaction (PCR)

On the basis of end user the global mycology immunoassay testing market is segmented into

  • Hospitals
  • Clinical laboratories
  • Blood Banks
  • Research centers
  • others

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

Infant Positioning Aids Market Application, Trends, Growth, Opportunities and Worldwide Forecast to 2027

Infant Positioning Aids Market: Market Overview

Global Infant Positioning Aids market has witnessed a robust growth due to increasing demand due to rising prevalence of sudden infant death syndrome. Infant Positioning Aids market has a presence of many regional players which have a huge market share in emerging countries operating at regional or country level. There are huge opportunities for the untapped markets in emerging countries due to few approved players of the infant positioning aids. The key players in the infant positioning aids market are mainly focused on expansion by collaborations and partnerships with local vendors in increase the market reach of the products. The future of Infant Positioning Aids market anticipated with double CAGR during forecasting period.

Infant Positioning Aids systems are intended to keep infants intact by using external support in order optimize biomechanical alignment, to enhance sensorimotor experiences, skeletal development and support medical conditions. They are aimed to maintain and improve the autonomic and physiological status of the infants. Infant positioning aids facilitate flexion in trunk and limbs appropriately for gestational maturation. They facilitate mobility, support self-regulatory behaviors and prevent delays in development. The goal of infant positioning includes not only promoting physiological flexion, but also the prevention of hips external rotation and head flattering. They are used in the prevention of asymmetrical movement and posture by promoting midline orientation. Traditional infant positioning aids such as boundaries and swaddling’s are used to maintain midline orientation and physiological flexion. Swaddlings are used to improve neuromuscular development, improved sleep, decreased startles, improved self-regulation and decrease stress. Boundaries are used to improve postural and motor behavior development, to decrease abrupt movements and to improve midline movements. Alternatives infant positioning aids are designed to allow movement of extremities along with containment of the infant.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-5261

Infant Positioning Aids Market: Drivers and Restraints

Due to advances in neonatal and prenatal care, there is an increase in survival rates of preterm infants, but the risk of neurodevelopment remains high along with increased risk for motor problems, cerebral palsy and cognitive delays. Infant positioning in physiological flexion is the newborn’s ideal position and it promotes joint symmetry and alignment, promotes behavioral organization and self-soothing and neuromuscular development. Effective infant positioning can reduce asymmetry in the infants. All these factors act as a driver in the burgeoning growth of the infant positioning aids market. Along with these, other factors like increasing demand for infant positioning aids to reduce sudden infant death syndrome. Rising prevalence of sudden infant death syndrome is driving towards fast growth of the infant positioning aids market

Regulatory pressure (In 2010, CPSC and FDA have issued a joint warning against the use of infant positioning aids) and limited availability of evidence based data for the effectiveness of infant aids is limiting the growth of the infant positioning aids market

Infant Positioning Aids Market: Key Participants

The key participants in the Infant Positioning Aids market mainly include Koninklijke Philips N.V. and others. Companies are mainly focused on R&D to strengthen core competencies of the company’s product portfolio.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also includes projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends and Issues and Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain
Infant Positioning Aids Market: Segmentation

Segmentation based on End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Center

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-5261

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

Angio Suites Market is Booming Worldwide by 2028 | Growth, Share, Demand and Analysis Forecasts

Siemens leads the packs globally, FMI offers an extensive assessment of the competitive landscape of angio suites market for 2018-2028

With an estimated incremental opportunity of more than US$ 100 million over 2018, the global revenue through sales of angio suites is likely to approach US$ 1.9 Bn in 2019. As reported by a new research intelligence study on the global angio suites market, there will be more than 6% year on year revenue growth in 2019 – reflecting a healthy outlook for the angio suites landscape at a global level.

Key Research Insights Drawn from the Report

  • In a consolidated market structure, the top three companies operating in the global angio suites landscape hold a whopping revenue share of around 70%.
  • Easy, fast-track FDA clearance holds vital importance in shaping the new product developments and launches.
  • Innovative therapy suites and angio suites are receiving wider platforms in recent years, with growing government funds and consistently increasing voluntary funds – pushing R&D activities further.

More than 1/4th Share of the Market Revenue Belongs to Siemens

Siemens AG, reportedly the global leader in angio suites landscape, has been highly active in terms of innovation in recent years.

  • The company had announced the launch of two products adding value to its innovative offerings in Nov 2017. Siemens Healthineers unveiled two imaging therapy suites that are intraoperative and possess multi-modality imaging capability. While interventional surgeons and radiologists are continuously striving to discover novel procedures that are highly precise yet rapid and affordable, Siemens’ Angio-MR-CT and Angio-CT therapy suites have been presented as a breakthrough innovative solution.
  • Later the same year, the company entered a 10-year contractual partnership with Kingston Hospital NHS Foundation Trust over the supply of all-inclusive Managed Equipment Services (MES) to the trust for a wide range of medical imaging systems.

The other two market leaders include Philips Healthcare and GE Healthcare LLC, which are prominently concentrating on innovative product launches for global expansion and introduction of disruptive technology based systems across developing regional markets.

Explaining the most popular developmental strategies adopted by key companies in angio suites landscape, the FMI analyst says, “The strategic focus of angio suites market players is likely to remain on vertical and horizontal integration. Our research concludes that direct selling strategy is allowing companies to cater to the escalating demand for technically innovated products”. Discussing further about the growing significance of having a strong distribution network, “Key players are also prioritizing a stronger distribution network at a global level. Whereas, development of independent distribution channels for personal selling of angio suites is also identified to be one of the key trends among market players,” says the analyst.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-7758

Segmental Analysis: Single Plane Angio Suites and Hospitals Remain Top Performing Segments

  • With more than 65% share of the global market revenue, single plane angio suites continue to dominate biplane angio suites, according to the report.
  • Although cath labs are likely to demonstrate impressive adoption of angio suites in the near future, hospitals remain the largest end user of angio suites.
  • Currently, Asia Pacific accounts for over 45% share of the total market revenue, followed by Europe that holds around 30% share in the market value.

The report projects emergence of lucrative business opportunities in developing regional markets, besides APAC, i.e. MEA and Latin America. While the opportunity assessment of emerging regional markets for angio suites analyses the sales force expansion and third party payer coverage in the regions, remarkable reimbursement support and improving customer care are identified to be the primary factors boosting revenue growth of angio suites market in these regions. In a bid to achieve high operational efficiency, a number of companies are strategizing the shifting of their manufacturing facilities to low-cost production bases in emerging economies of Latin America and APAC.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-7758

Segmentation

The report offers a comprehensive taxonomy of the angio suites market on the basis of product type, end user and region. On the basis of product type, the global angio suites market has been segmented into biplane angio suites and single plane angio suites.

On the basis of end user, the global angio suites market has been segmented into hospitals and cath labs. From a geographical perspective, the angio suites market has been segmented into North America, Latin America, Europe, Asia Pacific and Middle East & Africa (MEA).

Frontotemporal Disorders Treatment Market to reach a valuation of US$ 451.4 Million by 2028

[213 Pages Report] With the severe dearth of FDA-approved drugs in the reliable treatment of frontotemporal disorders, frontotemporal disorders treatment continues to underscore the growing significance of disease management. As frontotemporal disorders treatment exclusively includes symptomatic efforts till date, the condition continues to attract research interests worldwide.

The available drugs and other means of frontotemporal disorders treatment do not stop or even decelerate the frontotemporal disorders progression, which further remains a key driving force for the growing demand for frontotemporal disorders treatment.

Frontotemporal disorders are often misdiagnosed as depression, Parkinson’s, Alzheimer’s, or any other psychiatric condition, thereby limiting the scope of adoption of frontotemporal disorders treatment.

Although clinical trials have been producing a number of interventions other than medication, a consistently high rate of clinical trial failure is cited as a significant factor influencing the prospects of frontotemporal disorders treatment in the near future.

The report highlights the critical role of governments as well as non-governmental non-profit organizations in terms of research grants and drug approvals. Expanding incentives for orphan drug development is identified as a prominent factor pushing the revenue growth of frontotemporal disorders treatment landscape.

Demonstrating a moderate growth in the revenue year on year, the global landscape of frontotemporal disorders treatment market is slated to approach the US$ 3 billion mark in 2022. As presented in a newly published research intelligence on the global market scenario of frontotemporal disorders treatment, the revenue growth is predominantly driven by the progressing pace of clinical trials.

Discussing the revelations made by the study, says a senior research analyst at Future Market Insights says, “Although frontotemporal disorders are referred to as a symptomatic condition that has not witnessed a curative treatment as of now, an extensive clinical research targeting the discovery of breakthrough curative treatments is driving the growth of revenue at a steady rate”.

Strategic Collaborations Are Shaping the Competition in Fragmented Market

In a highly fragmented landscape of the global frontotemporal disorders treatment market, almost 70% of the companies offer generics as their key drug offerings. Operated by a large number of prominent international, multinational, and regional players, the market for frontotemporal disorders treatment is recently witnessing a heap of strategic deals, including acquisitions, collaborations, and alliances.

2017 was a year of partnerships for GlaxoSmithKline Plc. The company entered multiple strategic collaborations with giants such as Google and Alimama for improved marketing and advertising results. Further, with an objective to push the new drug discovery platform, GSK also signed a four-year contractual partnership with 23andMe. This deal is more likely to speed up the overall clinical progress in frontotemporal disorders treatment.

Moreover, several companies are constantly taking efforts in introducing new potential drugs post successful clinical trials, in the existing line of frontotemporal disorders treatment.

AstraZeneca plc. has recently inked an agreement with Luye Pharma Group, Ltd. over the licensing and sales of Seroquel and Seroquel XR across China, and the UK, in addition to a few other international markets. The drug is occasionally used to address a set of behavioral problems associated with FTD.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-5033

According to the taxonomy analysis of frontotemporal disorders treatment market presented in the report,

  • Cognitive enhancers are currently contributing around 80% share in the total market value, securing the position of the most favored drug class incorporated in the treatment of frontotemporal disorders.
  • On the other side, behavioral symptom management remains the most preferred type of treatment for patients of frontotemporal disorders, thereby accounting for nearly 60% share of the revenue generated in the global frontotemporal disorders treatment market.
  • An extensive analysis of the frontotemporal disorders treatment landscape uncovers that around half of the market value belongs to the retail pharmacy segment, making it the most popular distribution channel for frontotemporal disorder drugs.
  • Hospital pharmacies remain the second largest channel of distributioni in the frontotemporal disorders market, says the report.

Frontotemporal Dementia Is Highly Prevalent

Based on the symptomatic indication, frontotemporal dementia (FTD), holding a massive market value share, remains the most common indication among all that continues to capture maximum clinical research interests.

Industry experts project that the rapid development of new FTD therapies will push collaborative activities among clinical research entities, educational institutions, academic laboratories, pharma and biotech centers, and the FDA.

Furthermore, FTD therapeutics are anticipated to witness a major contribution from pharmaceutical companies – eventually boosting the funding and clinical trial scenario.

Western Europe Accounts for the Lion’s Share in Market Value

Western Europe and North America collectively extend more than 55% share in the total market value, the former’s share is however projected to remain higher over the foreseeable future. APEJ, with an attractive revenue contribution at present, is projected to remain a highly lucrative regional market for potential investors in the frontotemporal disorders treatment landscape.

While rapidly growing FTD prevalence and the expanding ongoing clinical trials platform are providing a collective push to frontotemporal disorders treatment market in Western Europe, research estimates rapid emergence of Asian economies owing to increasing sophistication of the region’s healthcare sector and gradually surging awareness about frontotemporal disorders.

Key Segments of Frontotemporal Disorders Treatment Industry Research

By Drug Class:

  • Cognitive Enhancers
  • Antipsychotics
  • Antidepressants
  • CNS Stimulants
  • Others

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-5033

By Treatment:

  • Behavioral Symptoms Management
  • Psychological Symptoms Management

By Disease Indication:

  • Frontotemporal Dementia
  • Primary Progressive Aphasia
  • Movement Disorders

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

Chemotherapy-Induced Myelosuppression Treatment Market to US$ 9.59 Billion through 2028

[211 pages Report] A new study by FMI reveals that the chemotherapy-induced myelosuppression treatment market is expected to grow at a subdued 3% y-o-y in 2019. Valued at nearly US$ 7 billion in 2018, gains are likely to be driven by a combination of multipronged factors, including,

  • Development of natural product interventions for chemotherapy-induced side effects
  • Growing implementation of radiation treatment in cancer treatment owing to the associated high success rate of chemotherapy
  • Growing R&D investments in cancer research

The FMI study finds that ‘growth factor’ drugs continued to garner highest revenues in the chemotherapy-induced myelosuppression treatment market. In 2018, over 73% of the chemotherapy-induced myelosuppression treatment market revenues were consolidated in the growth factors. Gains were especially notable for granulocyte-colony stimulating factor or G-CSF, which accounted for over 60% of the global chemotherapy-induced myelosuppression treatment market revenues in 2018.

The FMI study reveals that erythropoietin-stimulating agents (ESA) also accounted for a significant market share, with revenues likely to grow at 2.8% in 2019. In April 2017, FDA announced the removal of risk evaluation and mitigation strategy (REMS) requirement for the use of ESA drugs in myelosuppression treatment. The ESAs used in the treatment of radiation-induced myelosuppression treatment are epoetin alfa and darbepoetin alfa. This has led healthcare professionals to engage in the practice of discussing benefits as well as risks of treatments that include ESAs before initiating the use.

Hematopoietic growth factors have transformed the practice of cancer treatment by allowing stimulation of production of specific cells. With this, use of thrombopoietin receptor agonists is expected to rise rapidly at the rate of 3.5% in 2019.

Injectable Drugs Present Higher Therapeutic Availability over Orals

The FMI study finds that injectable drugs accounted for over 97% of the chemotherapy-induced myelosuppression treatment market revenues in 2018. The status-quo will continue in the future, however, the oral route of administration is expected to garner increasing annual revenues and expected to grow at 4.8% in 2019 over 2018.

Increasing number of research validations related to the benefits of the oral route of administration can be attributed to the higher growth rate of the segment in the future. However, revenues from the injectable route of the administration continue to grow steadily on the back of their higher therapeutic availability over orally administered drugs.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-1364

Market Revenues Consolidated in Neutropenia Treatment

According to the study, chemotherapy-induced myelosuppression treatment market revenues heavily consolidated in the neutropenia treatment. In 2018, neutropenia indication accounted for over 62% of market revenues. As neutropenia is one of the most common side effects of chemotherapy wherein prolongation of the same can lead to life-threatening infections. Owing to the severity of the implications, chemotherapy-induced myelosuppression therapeutics are heavily used in the treatment of neutropenia.

Anemia and thrombocytopenia indications also utilize chemotherapy-induced myelosuppression treatment therapeutics. The study finds that revenues in the thrombocytopenia treatment will grow at 3.7% y-o-y in 2019.

Retail Pharmacies Most Prominent Sales Channel

The study opines that chemotherapy-induced myelosuppression treatment therapeutics sales remain higher through retail pharmacies. Suppliers of these therapeutics have extensive distribution network with international retail pharmacies. Due to this, retail pharmacies accounted for over 48% of the chemotherapy-induced myelosuppression treatment market revenues in 2018.

Owing to heavy integration of pharmacies in the hospitals, distribution of chemotherapy-induced myelosuppression treatment therapeutics through hospital pharmacies also account for a considerable share of the market revenues. The study finds that hospital pharmacies can be called the second largest distributor of chemotherapy-induced myelosuppression treatment therapeutics owing to their 45% of the market revenues.

US – The World’s Largest Chemotherapy-induced Myelosupression Treatment Market

FMI reveals that North America accounted for over 82% of the revenues in chemotherapy-induced myelosuppression treatment market in 2018. Presence of leading cancer therapeutics providers, significant R&D investments and established healthcare sector contribute to the bulk of market revenues. The U.S. remains the largest consumer of the chemotherapy-induced myelosuppression treatment market.

Market revenues in the APEJ region are likely to grow at higher rate owing to improving healthcare facility and growing penetration of advanced cancer care treatments. China, followed by India, accounts for the highest market revenues in APEJ owing to improving economic scenario and developing healthcare infrastructure.

The FMI report analyses chemotherapy-induced myelosuppression treatment market for the forecast period 2018-2028. As per the report, the chemotherapy-induced myelosuppression treatment market is estimated to grow at 3.2% CAGR through 2028.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1364

Key SegmentBased on indication 

  • neutropenia
  • anaemia
  • thrombocytopenia

Based on drug class

  • growth factors
  • erythropoietin stimulating agents
  • thrombopoietic agents
  • iron supplements
  • others

Based on route of administration

  • oral
  • injectable

Based on distribution channel

  • hospitals pharmacies
  • retail pharmacies
  • online pharmacies
  • drug stores

Based on regions

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Japan
  • Middle East & Africa (MEA)